333401-63-1

Upstream product

• 93-51-6 2-Methoxy-4-methylphenol 
• 33837-83-1 3-(1,1-dimethylethyl)-4-hydroxy-5-methoxybenzaldehyde 
• 77-78-1 dimethyl sulfate 
• 2505-15-9 6-(tert-butyl)-2-methoxy-4-methylphenol 
• 333401-61-9 5-bromomethyl-3-tert-butyl-1,2-dimethoxybenzene 
• 34582-29-1 1-(tert-butyl)-2,3-dimethoxy-5-methylbenzene 
• 333401-62-0 5-tert-butyl-3,4-dimethoxybenzyl alcohol 

Downstream Products

• 34582-29-1 1-(tert-butyl)-2,3-dimethoxy-5-methylbenzene 
• 333401-64-2 (rac)-4,5'-di-tert-butyl-6-methyl-2,3,3',4'-tetramethoxy-diphenylmethanol 
• 501912-09-0 2-(3-tert-butyl-4,5-dimethoxy-phenyl)-4,4,5,5-tetramethyl-imidazolidine-1,3-diol 
• 333401-66-4 4,5'-di-tert-butyl-6-methyl-2,3,3',4'-tetramethoxy-diphenylmethane 
• 333401-65-3 1,2-bis(5'-tert-butyl-3',4'-dimethoxyphenyl)ethane 

Relevant academic research and scientific papers

Encapsulation and release mechanisms in coordination polymer nanoparticles

The interplay of guest encapsulation and release mechanisms in nanoscale metal-organic vehicles and its effect on the drug-delivery kinetics of these materials were investigated through a new multidisciplinary approach. Two rationally-designed molecular g

First total synthesis of the mastigophorenes C and D and of simplified unnatural analogs

The first total synthesis of the mastigophorenes C (2) and D (3), natural 'dimeric' sesquiterpenes isolated from the liverwort Mastigophora diclados with interesting biological activities, is described. As previously for mastigophorenes A (1) and B, the divergent synthetic approach was first optimized on a simplified model system with a tert-butyl group instead of the chiral cyclopentyl residue, also in order to find more easily available compounds with similar or even improved biological activity.